Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

Share Price is delayed by 15 minutes
Get Live Data
81.70    -0.50 (-0.61%)
Bid:
81.20
Ask:
81.70
Spread: 0.50 (0.616%)
Market Cap: £228.93m
ESNT Live PriceLast checked at - London Stock Exchange

Intraday Essentra Share Chart

Directorate Change

7 Nov 2024 15:27

RNS Number : 4192L
Essentra plc
07 November 2024
 

 

 

 

 

ESSENTRA PLC

 

BOARD CHANGES

 

Further to the announcement on 10 September 2024, Essentra plc, a leading global manufacturer and provider of essential components and solutions, confirms that Rowan Baker was appointed to the Board as CFO on 5 November 2024. Jack Clarke will step down from the Board on 1 January 2025.

 

Further information please contact:

Essentra plc

Scott Fawcett, Chief Executive

Emma Reid, Company Secretary

 

Tel: +44 (0)1908 359100

FTI Consulting

Richard Mountain

Ariadna Peretz

FTI_essentra@fticonsulting.com

Tel: +44 (0)20 3727 1340

 

LEI: 5493007MOZNA03BVNE96

 

Notes to Editors

About Essentra plc

Essentra plc is a FTSE 250 company and a leading global manufacturer and provider of essential components and solutions, focusing on the manufacture and distribution of plastic injection moulded, vinyl dip moulded and metal items.

Headquartered in the United Kingdom, Essentra's global network extends to 28 countries worldwide and includes c.3,000 employees, 14 manufacturing facilities, 24 distribution centres and 33 sales & service centres serving c.69,000 customers with a rapid supply of low cost but essential products for a variety of applications in industries such as equipment manufacturing, automotive, fabrication, electronics, medical and renewable energy.

For further information, please visit www.essentraplc.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRBATMTTMBAI
Date   Source Headline
29th Oct 201812:35 pmRNSDirector/PDMR Shareholding
24th Oct 20189:58 amRNSDirector/PDMR Shareholding
23rd Oct 201810:06 amRNSDirector/PDMR Shareholding
19th Oct 20187:00 amRNSQ3 2018 Interim Management Statement
5th Oct 20189:20 amRNSDirector/PDMR Shareholding
2nd Oct 20182:41 pmRNSHolding(s) in Company
2nd Oct 20182:26 pmRNSTotal Voting Rights
24th Sep 20183:10 pmRNSDirector/PDMR Shareholding
5th Sep 20189:39 amRNSDirector/PDMR Shareholding
3rd Sep 20185:51 pmRNSTotal Voting Rights
8th Aug 20188:55 amRNSDirector/PDMR Shareholding
6th Aug 201812:16 pmRNSDirector/PDMR Shareholding
3rd Aug 20187:00 amRNSHalf-year Report
1st Aug 20182:35 pmRNSTotal Voting Rights
31st Jul 20187:00 amRNSDivestment of Swiftbrook in Packaging Division
25th Jul 201810:19 amRNSInvitation to HY 2018 Results Presentation
11th Jul 201810:12 amRNSRESTATEMENT OF 2017 RESULTS FOR NEW STRUCTURE
6th Jul 20187:00 amRNSAcquisition of Nolato Hertila in Components
2nd Jul 201812:00 pmRNSTotal Voting Rights
22nd Jun 20188:00 amRNSDirectorate Change
1st Jun 20189:47 amRNSTotal Voting Rights
30th May 20187:05 amRNSAppointment of new Chief Financial Officer
8th May 20189:51 amRNSDirector/PDMR Shareholding
1st May 201811:15 amRNSTotal Voting Rights
20th Apr 20184:29 pmRNS2018 AGM Results
19th Apr 20187:02 amRNSChange in Board Director
19th Apr 20187:00 amRNSTrading Statement
6th Apr 20183:54 pmRNSDirector/PDMR Shareholding
6th Apr 20183:53 pmRNSDirector/PDMR Shareholding
6th Apr 20183:53 pmRNSDirector/PDMR Shareholding
6th Apr 20183:49 pmRNSDirector/PDMR Shareholding
6th Apr 20183:46 pmRNSDirector/PDMR Shareholding
6th Apr 20183:45 pmRNSDirector/PDMR Shareholding
6th Apr 20183:44 pmRNSDirector/PDMR Shareholding
6th Apr 20182:47 pmRNSDirector/PDMR Shareholding
6th Apr 20182:46 pmRNSDirector/PDMR Shareholding
6th Apr 20182:44 pmRNSDirector/PDMR Shareholding
6th Apr 20182:43 pmRNSDirector/PDMR Shareholding
6th Apr 20189:38 amRNSDirector/PDMR Shareholding
3rd Apr 201810:19 amRNSTotal Voting Rights
29th Mar 20185:11 pmRNSDirector/PDMR Shareholding
29th Mar 20185:09 pmRNSDirector/PDMR Shareholding
29th Mar 20185:08 pmRNSDirector/PDMR Shareholding
29th Mar 20185:06 pmRNSDirector/PDMR Shareholding
29th Mar 20185:06 pmRNSDirector/PDMR Shareholding
29th Mar 20185:05 pmRNSDirector/PDMR Shareholding
29th Mar 20185:03 pmRNSDirector/PDMR Shareholding
29th Mar 20185:01 pmRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSDirector/PDMR Shareholding
22nd Mar 20187:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.